Journal profile · Multiple

Extracellular Vesicles and Circulating Nucleic Acids

ISSN 2767-6641 · OAE Publishing Inc. · UNITED STATES OF AMERICA · Quarterly · Founded 2020

Extracellular Vesicles and Circulating Nucleic Acids: CAS Zone 2 · Biology (2026 Xinrui edition); impact factor 8.5 (journal website); fully open access; APC about USD 2,600; median 100 days to acceptance (100 articles, last 24 months); 67 articles in 2025; indexed in ESCI and Scopus.

Impact factor8.5From the journal's website, latest value
CAS zoneZone 2 · Biology2026 Xinrui edition, major category
Review time100 daysMedian, submission to acceptance · 100 articles, last 24 months · PubMed
APCUSD 2,600Fully open access
Acceptance—No reports yet
Articles per year672025 · OpenAlex count

Scope

Aims, scope and focus

Extracellular Vesicles and Circulating Nucleic Acids is published by OAE Publishing Inc. and is classed under Biology in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Extracellular vesicles in disease, MicroRNA in disease regulation and interferon and immune responses, together about 61.7% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Extracellular Vesicles and Circulating Nucleic Acids provides an online platform for the sharing of research data, new methodology, reviews and commentaries in the areas of extracellular vesicles and circulating nucleic acids including DNA, RNA, and miRNA and their therapeutic use. The journal is committed to the rapid publication of original findings that increase our understanding of the molecular and cell biology, biogenesis, and origin of extracellular vesicles and circulating nucleic acids; and their use as biomarkers for the diagnosis, prognostication and surveillance of disease states, and in therapeutics. Manuscripts with clinical relevance are especially encouraged to promote the translation from basic science to clinical applications. The criteria for acceptance are scientific excellence and originality. All works involving the use of animals and human subjects must have been approved by institutional review committees and adhere to accepted international ethical standards.

From the journal's Aims & Scope

Research area (LetPub): Multiple

Editor-in-chief Yoke Peng LohPublisher website

Editorial board by country: 15 in mainland China (about 18%); most named United States 24, Mainland China 15, South Korea 5, Italy 5, Australia 5 (83 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Extracellular vesicles in diseaseBiochemistry, Genetics and Molecular Biology45.3%
  2. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology10.9%
  3. interferon and immune responsesImmunology and Microbiology5.5%
  4. Nanoplatforms for cancer theranosticsEngineering4.5%
  5. RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology3.7%
  6. Mesenchymal stem cell researchMedicine3.5%
  7. Bacterial Infections and VaccinesImmunology and Microbiology3.1%
  8. Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology2.3%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
LevelCategoryZone
MajorBiologyZone 2
MinorBiochemistry & Molecular BiologyZone 2
MinorCell BiologyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
8.5Publisher website ·
CiteScore 2026-06
6.6LetPub ·
CiteScore (publisher)
6.6Publisher website ·
SJR 2026-06
1.44LetPub ·
SNIP 2026-06
0.76LetPub ·
h-index
26OpenAlex ·
i10-index
76OpenAlex ·
2-year mean citedness
5.05OpenAlex ·
Self-citation rate
2.4%LetPub ·
Share of gold OA articles
75.93%LetPub ·

Volume

Articles per year
45LetPub ·
Articles per year (publisher) 2027
2,027Publisher website ·
Downloads per year (publisher)
252,692Publisher website ·

Articles by year OpenAlex count · 285 in total · the current year is incomplete

YearArticlesOpen accessCitations
20268075121
20256767339
20244343499
20233939894
20223131404
20212019472

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

100 daysMedian, submission to acceptance · P25–P75 85 days – 129 days

Acceptance to online
median 25 days (100 articles)
Submission to online
median 130 days
Sample
100 articles with submission and acceptance dates (123 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Desk decision
10 daysPublisher website ·
Submission to first decision
10 daysPublisher website ·
Peer review
Single anonymous peer reviewPublisher website

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
Publisher websiteUSD 2,600——

Other charges and waivers (author guidelines)

Other fees
Charged; see the journal's website for the amount

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers2, by deadline
  1. Topic: Extracellular Vesicle-Mediated Communication in the Gut–Liver–Brain AxisDeadline
  2. Topic: Single-Particle Analysis of Extracellular Vesicles: Advances in Nano-Flow Cytometry and Its Biomedical ApplicationsDeadline
Publisher website
What to prepare8 items from the author guidelines
Abstract
≤ 250 words
Keywords
3–8
Reference style
Numbered, in order of citation
First submission
Free format: the journal's layout is not required
Suggested reviewers
Optional
Graphical abstract
Required
Cover letter
Required
Not considered
preprint
Publisher website · model-extracted, each line checked against the text
Article types accepted16
  1. commentaryThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  2. editorialThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  3. letterThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  4. letter to editorA Letter to Editor is usually an open post-publication review of a paper from its readers, often critical of some aspect of a published paper.Length not stated
  5. meta-analysisThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  6. mini reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  7. mini review/reviewA Mini Review/Review article should provide readers with an in-depth understanding of a field by summarizing existing literature, and highlight key gaps and cha…Length not stated
  8. opinionThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  9. original articleThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  10. perspectivePerspective is a format for scholarly reviews and discussions of the primary research literature that are too technical for a Commentary but do not meet the cri…Length not stated
  11. research highlightResearch Highlights discuss the main advances made by the paper as well as putting the finds of the study into the proper context of the field.Length not stated
  12. reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  13. review articleThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  14. short communicationsShort Communications are articles that present groundbreaking preliminary results or significant findings that are part of a larger study over multiple years.Length not stated
  15. systematic reviewThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
  16. viewpointThere is no restriction on the number of figures, tables and references, provided that the manuscript is concise and comprehensive. The journal publishes Origin…Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
AI use 2.3.3.4 AI and AI-assisted tools Statement

AI-generated content must meet ethical standards; authors verify accuracy. Model summary

Authors should disclose in their manuscript the use of AI and AI-assisted technologies. Declaring the use of these technologies supports transparency and trust between authors, readers, reviewers, editors and contributors and facilitates compliance with the terms of use of the relevant tool or technology.If the manuscript does not involve this issue, state “Not applicable.” in this section.

Source ↗Publisher website ·
Authorship 4. Authorship

Authorship credit of OAE journals should be solely based on substantial contributions to a published study, as specified in the following four criteria:1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work;2. Drafting the work or revising it critically for important intellectual content;3. Final approval of the ve…

Source ↗Publisher website ·
Conflicts of interest 2.3.3.6 Conflicts of Interest

Authors must declare any potential conflicts of interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. If there are no conflicts of interest, please state "All authors declared that there are no conflicts of interest." in this section. Some authors may be bound by confidentiality agreements. In such cases, in place of itemiz…

Source ↗Publisher website ·
Data availability 2.3.3.3 Availability of Data and Materials

In order to maintain the integrity, transparency and reproducibility of research records, authors should include this section in their manuscripts, detailing where the data supporting their findings can be found. Data can be deposited into data repositories or published as supplementary information in the journal. Authors who cannot share their data should state that the data will not be shared an…

Source ↗Publisher website ·
Publication ethics 2.3.3.7 Ethical Approval and Consent to Participate

COPE member; adheres to Code of Conduct and Best Practice Guidelines. Model summary

Research involving human subjects, human material or human data must be performed in accordance with the Declaration of Helsinki and approved by an appropriate ethics committee. An informed consent to participate in the study should also be obtained from participants, or their parents or legal guardians for children under 16. A statement detailing the name of the ethics committee (including the re…

Source ↗Publisher website ·
License & copyright 1.2 Open Access and Copyright

The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.

Source ↗Publisher website ·
Open access 1.2 Open Access and Copyright

Gold Open Access under CC BY 4.0; authors retain copyright. Model summary

The journal adopts Gold Open Access publishing model and distributes content under the Creative Commons Attribution 4.0 International License. Copyright is retained by authors. Please make sure that you are well aware of these policies.

Source ↗Publisher website ·
Peer review 7.3 AI Use in Peer Review

Rigorous peer review with strict ethical policies. Model summary

Confidentiality requirements: Reviewers must not upload manuscripts/materials to AI platforms, as this: 1. Violates OAE’s confidentiality policies2. Risks intellectual property infringement3. May compromise personal data in identifiable content Review integrity standards: Peer review must remain human-driven – AI tools cannot replace critical scholarly judgment.Reviewers must not use AI for manusc…

Source ↗Publisher website ·
Trial registration / reporting guidelines 3.1.5 Trial Registration

OAE requires all authors to register all relevant clinical trials that are reported in manuscripts submitted. OAE follows the World Health Organization (WHO)'s definition of clinical trials: "A clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Interventions i…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
OAE Publishing Inc.
Country or region
UNITED STATES OF AMERICA
Language
English
Frequency
Quarterly
Founded
2020
ISSN
2767-6641
Official links

FAQ

Frequently asked questions about Extracellular Vesicles and Circulating Nucleic Acids

What CAS zone is Extracellular Vesicles and Circulating Nucleic Acids in?

In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Extracellular Vesicles and Circulating Nucleic Acids?

The journal's website gives an impact factor of 8.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 6.6, h-index 26.

How long does peer review take at Extracellular Vesicles and Circulating Nucleic Acids?

Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 85–129 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Extracellular Vesicles and Circulating Nucleic Acids?

According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–8; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Extracellular Vesicles and Circulating Nucleic Acids based?

Of the 83 board members whose country the journal's board page names, 15 (about 18%) are in mainland China; the countries named most often are United States (24), Mainland China (15) and South Korea (5). Counted from the institutions listed on the board page; for reference only.

Which databases index Extracellular Vesicles and Circulating Nucleic Acids?

According to LetPub and DOAJ records, Extracellular Vesicles and Circulating Nucleic Acids is indexed in ESCI and Scopus.

Is Extracellular Vesicles and Circulating Nucleic Acids open access, and what is the APC?

Extracellular Vesicles and Circulating Nucleic Acids is a fully open-access journal. APC about USD 2,600.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .